Effect of epimedium pubescen flavonoid on bone mineral status and bone turnover in male rats chronically exposed to cigarette smoke

BMC Musculoskeletal Disorders

Volumn 13, Issue , 2012, Pages

  Gao, Shu Guang ^a   Cheng, Ling ^a   Li, Kang Hua ^a,b   Liu, Wen He ^c   Xu, Mai ^a   Jiang, Wei ^a   Wei, Li Cheng ^a   Zhang, Fang Jie ^a   Xiao, Wen Feng ^a   Xiong, Yi Lin ^a   Tian, Jian ^a   Zeng, Chao ^a   Sun, Jin Peng ^a   Xie, Qiang ^a   Lei, Guang Hua ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c XIANGNAN UNIVERSITY   (China)

Author keywords

Bone histomorphometry; Bone mineral content; Bone mineral density; Bone turnover; Epimedium pubescen flavonoid; Smoking

Indexed keywords

CIGARETTE SMOKE; DRINKING WATER; EPIMEDIUM PUBESCEN FLAVONOID; FLAVONOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; EPIMEDIUM PUBESCEN; LONG TERM EXPOSURE; MALE; MEDICINAL PLANT; MORPHOMETRICS; NONHUMAN; PASSIVE SMOKING; RAT; TRABECULAR BONE;

ABSORPTIOMETRY, PHOTON; ANIMALS; BIOLOGICAL MARKERS; BIOMECHANICS; BONE DENSITY; BONE REMODELING; BONE RESORPTION; EPIMEDIUM; FEMUR; FLAVONES; LUMBAR VERTEBRAE; MALE; MICROSCOPY, ELECTRON, SCANNING; NICOTINE; OSTEOGENESIS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; TOBACCO SMOKE POLLUTION;

EID: 84862302281     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-13-105     Document Type: Article

References (47)

1. A small-cell lung cancer genome with complex signatures of tobacco exposure. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordõez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA, Campbell PJ, Nature 2010 463 184 190 10.1038/nature08629 20016488
2. Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice. Clauss M, Voswinckel R, Rajashekhar G, Sigua NL, Fehrenbach H, Rush NI, Schweitzer KS, Yildirim A Kamocki K, Fisher AJ, Gu Y, Safadi B, Nikam S, Hubbard WC, Tuder RM, Twigg HL, Presson RG, Sethi S, Petrache I, J Clin Invest 2011 121 2470 2479 10.1172/JCI43881 21576822
3. Exposure to smoke and its effects on pulmonary diseases. Götting M, Ph Addicks J, Spallek M, Jensen AM, Groneberg DA, Versicherungsmedizin 2011 63 11 16 German 21488384
4. Study Of Osteoporotic Fractures Research Group: The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the Study of Osteoporotic Fractures. Coleman AL, Seitzman RL, Cummings SR, Yu F, Cauley JA, Ensrud KE, Stone KL, Hochberg MC, Pedula KL, Thomas EL, Mangione CM, Am J Ophthalmol 2010 149 160 169 10.1016/j.ajo.2009.07.025 19796757
5. The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: a pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort. Giampietro PF, McCarty C, Mukesh B, McKiernan F, Wilson D, Shuldiner A, Liu J, LeVasseur J, Ivacic L, Kitchner T, Ghebranious N, Osteoporos Int 2010 21 467 477 10.1007/s00198-009-0981-3 19506792
6. The influence of smoking on bone loss and response to nasal estradiol. Bjarnason NH, Nielsen TF, Jørgensen HL, Christiansen C, Climacteric 2009 12 59 65 10.1080/13697130802587689 19058059
7. Smoking status as a predictor of hip fracture risk in postmenopausal women of northwest Texas. Jenkins MR, Denison AV, Prev Chronic Dis 2008 5 09 18081998
8. The effects of smoking on bone health. Wong PK, Christie JJ, Wark JD, Clin Sci (Lond) 2007 113 233 241 10.1042/CS20060173
9. Determinants of smoking and cessation in older women. Donzé J, Ruffieux C, Cornuz J, Age Ageing 2007 36 53 57 17264137
10. Impact of smoking cessation on bone mineral density in postmenopausal women. Oncken C, Prestwood K, Kleppinger A, Wang Y, Cooney J, Raisz L, J Womens Health (Larchmt) 2006 15 1141 1150 10.1089/jwh.2006.15.1141
11. Smoking and quantitative ultrasound parameters in the calcaneus in 36-year-old men and women. Bernaards CM, Twisk JW, Snel J, van Mechelen W, Lips P, Kemper HC, Osteoporos Int 2004 15 735 741 14997288
12. Smoking and fracture risk: a meta-analysis. Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Osteoporosis Int 2005 16 155 156
13. Smoking is associated with lower bone mineral density and reduced cortical thickness in young men. Lorentzon M, Mellstrom D, Haug E, Ohlsson C, J Clin Endocrinol Metab 2007 92 497 503 17077132
14. The effect of systemic nicotine on osseointegration of titanium implants in the rat femur. Berley J, Yamano S, Sukotjo C, J Oral Implantol 2010 36 185 193 10.1563/AAID-JOI-D-09-00050 20553172
15. Effects of nicotine on gene expression and osseointegration in rats. Yamano S, Berley JA, Kuo WP, Gallucci GO, Weber HP, Sukotjo C, Clin Oral Implants Res 2010 21 1353 1359 10.1111/j.1600-0501.2010.01955.x 20626419
16. Phytoestrogen-rich herb formula "XLGB" prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats. Qin L, Zhang G, Hung WY, Shi Y, Leung K, Yeung HY, Leung P, J Bone Miner Metab 2005 23 55 61 10.1007/BF03026324 15984415
17. Regulation of Cbfa1 expression by total flavonoids of Herba epimedii. Qian G, Zhang X, Lu L, Wu X, Li S, Meng J, Endocr J 2006 53 87 94 10.1507/endocrj.53.87 16543677
18. Effect of kidney-tonifying herbs on ovary function and bone mass in postmenopausal women. An SJ, Li T, Li E, Chin J Osteoporosis 2000 6 55 59 Chinese
19. Tobacco smoke exposure alters cholestryl esterase activities and causes accumulation of cholesteryl esters in the rat aorta. Maehira F, Miyagi I, Kawano N, Kawano M, Shinjoh S, J Clin Biochem Nutr 1995 18 145 155 10.3164/jcbn.18.145
20. Dramatic decreases in brain reward function during nicotine withdrawal. Epping-Jordan MP, Watkins SS, Koob GF, Markou A, Nature 1998 393 76 79 10.1038/30001 9590692
21. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat. Gasser JA, Ingold P, Venturiere A, Shen V, Green JR, J Bone Miner Res 2008 23 544 551 18072878
22. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis. Deyhim F, Stoecker BJ, Brusewitz GH, Devareddy L, Arjmandi BH, Menopause 2005 12 755 762 10.1097/01.gme.0000185486.55758.5b 16278620
23. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, J Bone Miner Res 1987 2 595 610 3455637
24. Bone turnover in passive smoking female rat: relationships to change in bone mineral density. Gao SG, Li KH, Xu M, Jiang W, Shen H, Luo W, Xu WS, Tian J, Lei GH, BMC Musculoskelet Disord 2011 12 131 10.1186/1471-2474-12-131 21663694
25. The influence of cigarette smoke inhalation on bone density. A radiographic study in rats. César-Neto JB, Benatti BB, Manzi FR, Sallum EA, Sallum AW, Nociti FH, Braz Oral Res 2005 19 47 51 16229356
26. Impact of passive smoking on the bones of rats. Ajiro Y, Tokuhashi Y, Matsuzaki H, Nakajima S, Ogawa T, Orthopedics 2010 33 90 95 10.3928/01477447- 20100104-14 20192148
27. Negative effects of nicotine on bone-resorbing cytokines and bone histomorphometric parameters in male rats. Hapidin H, Othman F, Soelaiman IN, Shuid AN, Luke DA, Mohamed N, J Bone Miner Metab 2007 25 93 98 10.1007/s00774-006-0733-9 17323178
28. Smoking, smoking cessation, and risk of hip fracture in women. Cornuz J, Feskanich D, Willett WC, Colditz GA, Am J Med 1999 106 311 314 10.1016/S0002-9343(99)00022-4 10190380
29. Premenopausal smoking and bone density in 2015 perimenopausal women. Hermann AP, Brot C, Gram J, Kolthoff N, Mosekilde L, J Bone Miner Res 2000 15 780 787 10780870
30. The effect of chronic nicotine administration on bone mineral content and bone strength in normal and castrated male rats. Broulik PD, Rosenkrancová J, Rzicka P, Sedlácek R, Kurcová I, Horm Metab Res 2007 39 20 24 10.1055/s-2007-957342 17226109
31. Effects of nicotine administration and nicotine cessation on bone histomorphometry and bone biomarkers in Sprague-Dawley male rats. Hapidin H, Othman F, Soelaiman IN, Shuid AN, Mohamed N, Calcif Tissue Int 2011 88 41 47 10.1007/s00223-010-9426-4 20953592
32. Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Zhang G, Qin L, Hung WY, Shi YY, Leung PC, Yeung HY, Leung KS, Bone 2006 38 818 825 10.1016/j.bone.2005.11.019 16413840
33. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. Zhang G, Qin L, Shi Y, J Bone Miner Res 2007 22 1072 1079 10.1359/jbmr.070405 17419678
34. Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts. Zhang DW, Cheng Y, Wang NL, Zhang JC, Yang MS, Yao XS, Phytomedicine 2008 15 55 61 10.1016/j.phymed.2007.04.002 17482445
35. Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner. Zhao J, Ohba S, Shinkai M, Chung UI, Nagamune T, Biochem Biophys Res Commun 2008 369 444 448 10.1016/j.bbrc.2008.02.054 18295595
36. Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression. Hsieh TP, Sheu SY, Sun JS, Chen MH, Liu MH, Phytomedicine 2010 17 414 423 10.1016/j.phymed.2009.08.007 19747809
37. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-B regulated HIF-1 and PGE(2) synthesis. Hsieh TP, Sheu SY, Sun JS, Chen MH, Phytomedicine 2011 18 176 185 10.1016/j.phymed.2010.04.003 20554188
38. Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Chen KM, Ge BF, Liu XY, Ma PH, Lu MB, Bai MH, Wang Y, Pharmazie 2007 62 388 391 17557750
39. Antiosteoporotic activity of icariin in ovariectomized rats. Nian H, Ma MH, Nian SS, Xu LL, Phytomedicine 2009 16 320 326 10.1016/j.phymed.2008.12.006 19269147
40. Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. Chen KM, Ge BF, Ma HP, Liu XY, Bai MH, Wang Y, Pharmazie 2005 60 939 942 16398272
41. Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Sugimoto E, Yamaguchi M, Int J Mol Med 2000 5 515 520 10762655
42. Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells. Sugimoto E, Yamaguchi M, Biochem Pharmacol 2000 59 471 475 10.1016/S0006-2952(99)00351-2 10660113
43. Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: Activation of aminoacyl-t-RNA synthetase. Yamaguchi M, Sugimoto E, Mol Cell Biochem 2000 214 97 102 10.1023/A:1007199120295 11195796
44. Effects of nicotine on proliferation and osteoblast differentiation in human alveolar bone marrow-derived mesenchymal stem cells. Kim BS, Kim SJ, Kim HJ, Lee SJ, Park YJ, Lee J, You HK, Life Sci 2012 90 109 115 10.1016/j.lfs.2011.10.019 22115820
45. Influence of nicotine on the biological activity of rabbit osteoblasts. Ma L, Zwahlen RA, Zheng LW, Sham MH, Clin Oral Implants Res 2011 22 338 342 10.1111/j.1600-0501.2010.02088.x 21561475
46. Nicotinic modulation of gene expression in osteoblast cells, MG-63. Rothem DE, Rothem L, Dahan A, Eliakim R, Soudry M, Bone 2011 48 903 909 10.1016/j.bone.2010.12.007 21168537
47. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plaveti K, Müller R, Bilezikian J, Lindsay R, J Bone Miner Res 2001 16 1846 1853 10.1359/jbmr.2001.16.10.1846 11585349